Clinical Trial Update: Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study evaluating a triplet regimen of Navitoclax, Venetoclax, and Decitabine for relapsed or refractory acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Navitoclax (navitoclax)
• Venetoclax (venetoclax)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING